PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24484870-6 2014 Either ectopic expression of miR-125a or inhibition of ErbB via Mubritinib resulted in inhibition of cell cycle proliferation and progression with enhanced apoptosis revealing ErbB inhibitors as potential novel therapeutic agents for treating miR-125a-low AML. TAK-165 64-74 epidermal growth factor receptor Homo sapiens 55-59 24484870-6 2014 Either ectopic expression of miR-125a or inhibition of ErbB via Mubritinib resulted in inhibition of cell cycle proliferation and progression with enhanced apoptosis revealing ErbB inhibitors as potential novel therapeutic agents for treating miR-125a-low AML. TAK-165 64-74 epidermal growth factor receptor Homo sapiens 176-180